162 related articles for article (PubMed ID: 34250396)
1. Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
Seet AOL; Tan AC; Tan TJ; Ng MCH; Tai DWM; Lam JYC; Tan GS; Gogna A; Too CW; Tan BS; Takano A; Lim A; Lim TH; Lim ST; Dent RA; Ang MK; Yap YS; Tan IBH; Choo SP; Toh CK; Lim EH; Farid M; Skanderup AJ; Iyer NG; Lim WT; Tan EH; Lim TKH; Tan DSW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250396
[TBL] [Abstract][Full Text] [Related]
2. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Bertucci F; Gonçalves A; Guille A; Adelaïde J; Garnier S; Carbuccia N; Billon E; Finetti P; Sfumato P; Monneur A; Pécheux C; Khran M; Brunelle S; Mescam L; Thomassin-Piana J; Poizat F; Charafe-Jauffret E; Turrini O; Lambaudie E; Provansal M; Extra JM; Madroszyk A; Gilabert M; Sabatier R; Vicier C; Mamessier E; Chabannon C; Pakradouni J; Viens P; André F; Gravis G; Popovici C; Birnbaum D; Chaffanet M
Genome Med; 2021 May; 13(1):87. PubMed ID: 34006291
[TBL] [Abstract][Full Text] [Related]
3. Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
Kim SY; Kim JH; Kim TY; Park SR; Yoon S; Lee S; Lee SH; Kim TM; Han SW; Kim HR; Yun H; Lee S; Kim J; Choi YL; Choi KS; Chae H; Ryu H; Lee GW; Zang DY; Ahn JB
BMC Cancer; 2024 May; 24(1):574. PubMed ID: 38724991
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Reitsma M; Fox J; Borre PV; Cavanaugh M; Chudnovsky Y; Erlich RL; Gribbin TE; Anhorn R
J Manag Care Spec Pharm; 2019 May; 25(5):601-611. PubMed ID: 30632889
[TBL] [Abstract][Full Text] [Related]
5. Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.
Parsons HA; Beaver JA; Cimino-Mathews A; Ali SM; Axilbund J; Chu D; Connolly RM; Cochran RL; Croessmann S; Clark TA; Gocke CD; Jeter SC; Kennedy MR; Lauring J; Lee J; Lipson D; Miller VA; Otto GA; Rosner GL; Ross JS; Slater S; Stephens PJ; VanDenBerg DA; Wolff AC; Young LE; Zabransky DJ; Zhang Z; Zorzi J; Stearns V; Park BH
Clin Cancer Res; 2017 Jan; 23(2):379-386. PubMed ID: 27489289
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
[TBL] [Abstract][Full Text] [Related]
8. Oncologist use and perception of large panel next-generation tumor sequencing.
Schram AM; Reales D; Galle J; Cambria R; Durany R; Feldman D; Sherman E; Rosenberg J; D'Andrea G; Baxi S; Janjigian Y; Tap W; Dickler M; Baselga J; Taylor BS; Chakravarty D; Gao J; Schultz N; Solit DB; Berger MF; Hyman DM
Ann Oncol; 2017 Sep; 28(9):2298-2304. PubMed ID: 28911072
[TBL] [Abstract][Full Text] [Related]
9. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Patel SP; Schwaederle M; Daniels GA; Fanta PT; Schwab RB; Shimabukuro KA; Kesari S; Piccioni DE; Bazhenova LA; Helsten TL; Lippman SM; Parker BA; Kurzrock R
Oncotarget; 2015 Oct; 6(32):32602-9. PubMed ID: 26418953
[TBL] [Abstract][Full Text] [Related]
10. Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.
Popa AM; Stejeroiu MA; Iaciu C; Olaru M; Orlov Slavu C; Parosanu A; Stanciu IM; Pirlog C; Pavel S; Nitipir C
Cureus; 2023 Dec; 15(12):e50709. PubMed ID: 38111812
[TBL] [Abstract][Full Text] [Related]
11. Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in Singapore.
Tan DS; Tan DS; Tan IBH; Yan B; Choo SP; Chng WJ; Hwang WYK
Asia Pac J Clin Oncol; 2020 Aug; 16(4):222-231. PubMed ID: 32301274
[TBL] [Abstract][Full Text] [Related]
12. Implementing precision oncology for sarcoma patients: the CCC
Berclaz LM; Burkhard-Meier A; Lange P; Di Gioia D; Schmidt M; Knösel T; Klauschen F; von Bergwelt-Baildon M; Heinemann V; Greif PA; Westphalen CB; Heinrich K; Lindner LH
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13973-13983. PubMed ID: 37542550
[TBL] [Abstract][Full Text] [Related]
13. Personalized oncology through integrative high-throughput sequencing: a pilot study.
Roychowdhury S; Iyer MK; Robinson DR; Lonigro RJ; Wu YM; Cao X; Kalyana-Sundaram S; Sam L; Balbin OA; Quist MJ; Barrette T; Everett J; Siddiqui J; Kunju LP; Navone N; Araujo JC; Troncoso P; Logothetis CJ; Innis JW; Smith DC; Lao CD; Kim SY; Roberts JS; Gruber SB; Pienta KJ; Talpaz M; Chinnaiyan AM
Sci Transl Med; 2011 Nov; 3(111):111ra121. PubMed ID: 22133722
[TBL] [Abstract][Full Text] [Related]
14. Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.
Jin G; Wang C; Jia D; Qian W; Yin C; Wang D; Yang Q; Li T; Zheng A
Technol Cancer Res Treat; 2021; 20():15330338211068964. PubMed ID: 34939467
[No Abstract] [Full Text] [Related]
15. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Trédan O; Wang Q; Pissaloux D; Cassier P; de la Fouchardière A; Fayette J; Desseigne F; Ray-Coquard I; de la Fouchardière C; Frappaz D; Heudel PE; Bonneville-Levard A; Fléchon A; Sarabi M; Guibert P; Bachelot T; Pérol M; You B; Bonnin N; Collard O; Leyronnas C; Attignon V; Baudet C; Sohier E; Villemin JP; Viari A; Boyault S; Lantuejoul S; Paindavoine S; Treillleux I; Rodriguez C; Agrapart V; Corset V; Garin G; Chabaud S; Pérol D; Blay JY;
Ann Oncol; 2019 May; 30(5):757-765. PubMed ID: 30865223
[TBL] [Abstract][Full Text] [Related]
16. IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Puco K; Fagereng GL; Brabrand S; Niehusmann P; Støre Blix E; Samdal Steinskog ES; Haug Å; Fredvik Torkildsen C; Oppedal IA; Meltzer S; Flobak Å; Johansson KAM; Bjørge L; Hjortland GO; Dalhaug A; Lund JÅ; Gilje B; Grønlie Cameron M; Hovland R; Falk RS; Smeland S; Giercksky Russnes HE; Taskén K; Helland Å; ;
Acta Oncol; 2024 May; 63():379-384. PubMed ID: 38779911
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.
Tao K; Yamazaki F; Kubo T; Sunami K; Kumamoto T; Arakawa A; Sugiyama M; Watanabe Y; Nakajima M; Shirakawa N; Tanimura K; Koyama T; Hirata M; Sudo K; Tanabe N; Watanabe T; Yoshida T; Kitami M; Yoshida A; Yatabe Y; Nakano Y; Ohira M; Kamijo T; Nakazawa A; Kato M; Ichimura K; Kohno T; Yamamoto N; Hishiki T; Ichikawa H; Ogawa C
JCO Precis Oncol; 2023 Jul; 7():e2200266. PubMed ID: 37410973
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.
Sunami K; Ichikawa H; Kubo T; Kato M; Fujiwara Y; Shimomura A; Koyama T; Kakishima H; Kitami M; Matsushita H; Furukawa E; Narushima D; Nagai M; Taniguchi H; Motoi N; Sekine S; Maeshima A; Mori T; Watanabe R; Yoshida M; Yoshida A; Yoshida H; Satomi K; Sukeda A; Hashimoto T; Shimizu T; Iwasa S; Yonemori K; Kato K; Morizane C; Ogawa C; Tanabe N; Sugano K; Hiraoka N; Tamura K; Yoshida T; Fujiwara Y; Ochiai A; Yamamoto N; Kohno T
Cancer Sci; 2019 Apr; 110(4):1480-1490. PubMed ID: 30742731
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital.
Teuwen LA; Roets E; D'Hoore P; Pauwels P; Prenen H
Diagnostics (Basel); 2023 May; 13(9):. PubMed ID: 37175010
[TBL] [Abstract][Full Text] [Related]
20. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
